SCHEMBL11258895

SCHEMBL11258895

CCCCCCCCCCCCCCCCNc1ccc(C(=O)CCC(=O)O)cc1F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR3 P49019 2/20 0.47
MMP2 P08253 1/20 0.46
MMP12 P39900 1/20 0.46
PLK1 P53350 3/20 0.45
THRA P10827 2/20 0.45
THRB P10828 2/20 0.45
L3MBTL1 Q9Y468 1/20 0.43
ALDH1A1 P00352 3/20 0.42
HPGD P15428 3/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2C19 P33261 1/20 0.42
HSD17B10 Q99714 1/20 0.42
RAB9A P51151 3/20 0.41
MAPT P10636 2/20 0.41
EPHX2 P34913 1/20 0.41
HTR7 P34969 1/20 0.41
NPC1 O15118 2/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11250351 0.90 HCAR3 (0.49) HCAR3PLK1THRATHRBEPHX2
SCHEMBL11260606 0.88 ALDH1A1 (0.50) HCAR3PLK1THRATHRBL3MBTL1
SCHEMBL11255414 0.85 HCAR3 (0.62) HCAR3PLK1THRBALDH1A1HPGD
SCHEMBL15412525 0.85 HCAR3 (0.62) HCAR3PLK1THRBALDH1A1HPGD
SCHEMBL11262794 0.84 HCAR3 (0.61) HCAR3PLK1THRBALDH1A1HPGD
SCHEMBL11258316 0.83 HCAR3 (0.49) HCAR3PLK1L3MBTL1ALDH1A1MAPT
SCHEMBL11559109 0.81 MMP2 (0.56) MMP2MMP12PLK1THRATHRB
SCHEMBL11252842 0.81 S1PR1 (0.46) HCAR3PLK1THRATHRBHPGD
SCHEMBL11262791 0.81 HCAR3 (0.50) HCAR3PLK1L3MBTL1ALDH1A1HSD17B10
SCHEMBL11258578 0.81 MAPT (0.55) HCAR3PLK1L3MBTL1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4333940-A Ring-fluorinated 4-(monosubstituted-amino) phenyl compounds in inhibiting atherosclerotic lesion development AMERICAN CYANAMID COMPANY (US) 1982-06-08 US disclosed
US-4243609-A ANTILIPEMIC AGENTS, ANTIATHEROSCLEROTIC AGENTS AMERICAN CYANAMID COMPANY (US) 1981-01-06 US disclosed
EP-0003663-A2 Amino-substituted phenyl and heteroaryl compounds, process for their preparation and pharmaceutical compositions containing them AMERICAN CYANAMID COMPANY (US) 1979-08-22 EP disclosed